Correct way and time to take erdafitinib

Erdafitinib: As a targeted oral anti-cancer (bladder cancer) drug, its correct administration is crucial to its efficacy and safety. Patients need to strictly follow the doctor's instructions when taking the medication. The usually recommended starting dose is 8 mg once a day, taken orally. It is recommended to take it at approximately the same time every day to ensure stable blood concentration of the drug. If the doctor deems it necessary based on the patient's individual response, the dose can be adjusted gradually, but you should avoid increasing or decreasing the dose on your own. The medicine can be taken on an empty stomach or with food. It is not mandatory to take it before or after meals, but it is recommended to take it at a fixed time every day to improve compliance and efficacy.

Patients should pay attention to drinking plenty of water while taking the drug, and avoid using it with grapefruit and its products, because grapefruit may affect the metabolism of erdafitinib, thereby interfering with the efficacy or increasing the risk of side effects. In addition, if you have obvious side effects after taking the medicine, such as blurred vision, eye pain, dry skin, etc., you should inform your doctor in time. These side effects may be related to the extensive physiological effects of the FGFR pathway and require monitoring by the medical team and necessary dose adjustments.

During the course of treatment, doctors usually evaluate drug response based on biochemical indicators such as blood phosphorus levels and adjust the dose if necessary. For some patients, if phosphorus levels rise too quickly, doctors may direct a low-phosphorus diet or adjust the dose to avoid increased toxicity. It is worth noting that the efficacy evaluation is usually carried out after a few weeks, so patients should insist on taking the medication to avoid stopping the medication due to lack of short-term effects.

In short, the use of erdafitinib needs to be combined with accurate genetic testing results and doctor's guidance, regular follow-up monitoring indicators and adjustment of the plan to maximize the efficacy and reduce toxicity. It is an important practical path for current precision anti-cancer treatment.

References：https://www.balversa.com/